KHIDI: Pharmaceuticals and Cosmetics Drive 18% Year-on-Year Growth
Medical Device Exports Return to Growth in First Half After Four Years

In the first half of the year, exports from the domestic biohealth industry surpassed 16.1 billion dollars, marking the highest half-year performance on record. The industry's overall growth was driven by expanded exports of biopharmaceuticals to Europe, the continued global popularity of K-beauty products, and a return to growth in medical device exports.


Biohealth Exports Reach $16.1 Billion in First Half... "Record Half-Year Performance" View original image

According to the Korea Health Industry Development Institute on July 21, exports from the biohealth industry between January and June this year reached 16.12 billion dollars, a 17.5% increase compared to the same period last year (13.72 billion dollars). This is the largest half-year total ever recorded.


By category, pharmaceuticals increased by 14.1% to 6.06 billion dollars, medical devices rose by 5.9% to 3.08 billion dollars, and cosmetics surged by 26.9% to 6.98 billion dollars.


Among pharmaceuticals, biopharmaceuticals led the growth. Exports of biopharmaceuticals reached 3.97 billion dollars, up 18.6% year-on-year, setting a new half-year record. Notably, a sharp increase in exports to European markets such as Switzerland, the Netherlands, Italy, and Hungary contributed significantly to the overall improvement. Exports of bacterial toxins and toxoids also achieved record highs, rising 46.9% mainly to the United States, China, and Brazil.


For medical devices, supported by robust exports of ultrasound imaging devices and electrically operated medical equipment, first-half exports returned to growth for the first time in four years. Exports of ultrasound imaging devices increased by 10.3% to 480 million dollars, while electrically operated medical equipment rose by 14.5% to 340 million dollars.


Biohealth Exports Reach $16.1 Billion in First Half... "Record Half-Year Performance" View original image

Cosmetics exports, which showed the highest growth rate, reached a record high of 6.98 billion dollars. Basic cosmetics accounted for more than 78% of total cosmetics exports, increasing 33.1% to 5.47 billion dollars, with particularly strong growth witnessed in North American and European markets, including the United States, the United Kingdom, and the Netherlands. Personal cleansing products also rose by 25.3%, led by demand in the United States, Vietnam, and Japan.



Choi Youngim, Director of the Biohealth Innovation Planning Division at the Korea Health Industry Development Institute, said, "In the first half of this year, the biohealth industry maintained steady growth, with cosmetics and pharmaceuticals recording the highest half-year performances ever. We expect the upward trend in exports to continue in the second half as global demand for basic cosmetics and biopharmaceuticals remains strong."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing